Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: NEOADJUVANT TREATMENT, . Treffer: 34

2025

Banys-Paluchowski, M; Hartmann, S; Basali, T; Gasparri, ML; de, Boniface, J; Gentilini, OD; Cakmak, GK; Ditsch, N; Stickeler, E; Schlichting, E; Rubio, I; Peintinger, F; Untch, M; Mau, C; Federspiel, FK; Bucher, S; Ramaker, K; Paluchowski, P; Bauer, L; Riemer, S; Langanke, D; Leuf, TD; Schnabel, J; von, Abel, E; Solbach, C; Ovalle, SC; Hilmer, K; Bjelic-Radisic, V; Stahl, N; Sanchez-Mendez, JI; Hagen, V; Hansen, MH; Krawczyk, N; Sezen, BA; Jursik, K; Thill, M; Kolberg, HC; Reimer, T; Ruf, F; Wihlfahrt, K; Rief, A; Berger, T; Schmidt, E; Tauber, N; Fröhlich, S; Kühn, T Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.
Breast Cancer Res Treat. 2025; Doi: 10.1007/s10549-025-07635-4
Web of Science PubMed FullText FullText_MUG

 

2024

Harbeck, N; Wrobel, D; Zaiss, M; Terhaag, J; Guth, D; Distelrath, A; Zahn, MO; Wuerstlein, R; Lorenz, A; Bartsch, R; Breitenstein, U; Schwitter, M; Balic, M; Jackisch, C; Müller, V; Rinnerthaler, G; Schmidt, M; Zaman, K; Schinköthe, T; Resch, A; Valenti, R; Lüftner, D Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study.
Breast Care (Basel). 2024; 19(1):1-9 Doi: 10.1159/000533657 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

John, N; Schlintl, V; Sassmann, T; Lindenmann, J; Fediuk, M; Wurm, R; Douschan, P; Zacharias, M; Kalson, L; Posch, F; Absenger, G; Brcic, L; Jost, PJ; Terbuch, A Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC.
J Immunother Cancer. 2024; 12(4): Doi: 10.1136/jitc-2023-008592 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Terbuch, A; Konjic, S; Schlintl, V; Absenger, G; Jost, PJ; Lindenmann, J; Swatek, P; John, N; John, T; Wurm, R; Zacharias, M; Posch, F; Hochmair, MJ; Fabikan, H; Weinlinger, C; Illini, O; Horvath, L; Gamerith, G; Wolf, D; Augustin, F; Brcic, L Prognostic impact of targetable driver alterations in resected early-stage lung cancer.
Transl Lung Cancer Res. 2024; 13(11): 3096-3105. Doi: 10.21037/tlcr-24-433 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2023

Wimmer, K; Sachet, M; Ramos, C; Frantal, S; Birnleitner, H; Brostjan, C; Exner, R; Filipits, M; Bago-Horvath, Z; Rudas, M; Bartsch, R; Gnant, M; Singer, CF; Balic, M; Egle, D; Oehler, R; Fitzal, F Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients.
J Exp Clin Cancer Res. 2023; 42(1):300 Doi: 10.1186/s13046-023-02876-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2022

Gulla, A; Hashimoto, D; Wagner, D; Damaseviciute, R; Strupas, K; Satoi, S Interdisciplinary Approach of Establishing PDAC Resectability: Biochemical, Radiological and NAT Regimen Prognostic Factors-Literature Review.
Medicina (Kaunas). 2022; 58(6): Doi: 10.3390/medicina58060756 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Terbuch, A; Absenger, G Neoadjuvant treatment in non-small-cell lung cancer-the earlier, the better
MEMO-MAG EUR MED ONC. 2022; Doi: 10.1007/s12254-022-00828-3
Web of Science FullText FullText_MUG

 

Zhou, Q; Gampenrieder, SP; Frantal, S; Rinnerthaler, G; Singer, CF; Egle, D; Pfeiler, G; Bartsch, R; Wette, V; Pichler, A; Petru, E; Dubsky, PC; Bago-Horvath, Z; Fesl, C; Rudas, M; Ståhlberg, A; Graf, R; Weber, S; Dandachi, N; Filipits, M; Gnant, M; Balic, M; Heitzer, E Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response.
Clin Cancer Res. 2022; 28(4):697-707 Doi: 10.1158/1078-0432.CCR-21-3231 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2021

Balic, M; Rinnerthaler, G; Bartsch, R Position Paper on the Value of Extended Adjuvant Therapy with Neratinib for Early HER2+/HR+ Breast Cancer.
Breast Care (Basel). 2021; 16(6):664-676 Doi: 10.1159/000518696 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Bartsch, R; Singer, CF; Pfeiler, G; Hubalek, M; Stoeger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Muy-Kheng, TM; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.
Br J Cancer. 2021; 124(11): 1795-1802. Doi: 10.1038/s41416-021-01284-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Birrer, DL; Golcher, H; Casadei, R; Haile, SR; Fritsch, R; Hussung, S; Brunner, TB; Fietkau, R; Meyer, T; Grützmann, R; Merkel, S; Ricci, C; Ingaldi, C; Di, Marco, M; Guido, A; Serra, C; Minni, F; Pestalozzi, B; Petrowsky, H; DeOliveira, M; Bechstein, WO; Bruns, CJ; Oberkofler, CE; Puhan, M; Lesurtel, M; Heinrich, S; Clavien, PA Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data From 3 Randomized Controlled Trials.
Ann Surg. 2021; 274(5): 713-720. Doi: 10.1097/SLA.0000000000005126
Web of Science PubMed FullText FullText_MUG

 

Lunger, L; Retz, M; Bandur, M; Souchay, M; Vitzthum, E; Jäger, M; Weirich, G; Schuster, T; Autenrieth, M; Kübler, H; Maurer, T; Thalgott, M; Herkommer, K; Koll, F; Gschwend, JE; Nawroth, R; Heck, MM KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy.
Prostate Cancer Prostatic Dis. 2021; 24(2): 362-369. Doi: 10.1038/s41391-020-00283-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Mahlmann, JC; Wirth, TC; Hartleben, B; Schrem, H; Mahlmann, JF; Kaltenborn, A; Klempnauer, J; Kulik, U Chemotherapy and Hepatic Steatosis: Impact on Postoperative Morbidity and Survival after Liver Resection for Colorectal Liver Metastases
VISC MED. 2021; 37(3): 198-205. Doi: 10.1159/000510661 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2020

Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stöger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Maria Tea, MK; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M; Austrian Breast & Colorectal Cancer Study Group Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34).
Eur J Cancer. 2020; 132:43-52 Doi: 10.1016/j.ejca.2020.03.018
Web of Science PubMed FullText FullText_MUG

 

2019

Koch, OO; Weitzendorfer, M; Varga, M; Tschoner, A; Partl, R; Perathoner, A; Gehwolf, P; Kapp, KS; Függer, R; Öfner, D; Emmanuel, K Perioperative chemotherapy versus neoadjuvant chemoradiation for patients with adenocarcinoma of the distal esophagus in Austria: a retrospective analysis.
World J Surg Oncol. 2019; 17(1): 146-146. Doi: 10.1186/s12957-019-1693-6 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Cserni, G; Zombori, T; Andreu, X; Bianchi, S; Regitnig, P; Amendoeira, I; Balmativola, D; Kovács, A; Cordoba, A; Reiner, A; Kulka, J; Kaya, H; Liepniece-Karele, I; Quinn, C; Kővári, B Is Regression after Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Different in Sentinel and Non-sentinel Nodes?
Pathol Oncol Res. 2018; 24(1):167-170 Doi: 10.1007/s12253-017-0229-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kirste, S; Kayser, G; Zipfel, A; Grosu, AL; Brunner, T Unresectable hepatic PEComa: a rare malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection.
Radiat Oncol. 2018; 13(1):28 Doi: 10.1186/s13014-018-0974-5 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Richtig, E ASCO Congress 2018: melanoma treatment.
Memo. 2018; 11(4):261-265 Doi: 10.1007/s12254-018-0455-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schindl, M; Függer, R; Götzinger, P; Längle, F; Zitt, M; Stättner, S; Kornprat, P; Sahora, K; Hlauschek, D; Gnant, M; Austrian Breast and Colorectal Cancer Study Group Randomized clinical trial of the effect of a fibrin sealant patch on pancreatic fistula formation after pancreatoduodenectomy.
Br J Surg. 2018; 105(7):811-819 Doi: 10.1002/bjs.10840 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Tamandl, D; Ba-Ssalamah, A; Böhm, G; Emmanuel, K; Forstner, R; Függer, R; Henninger, B; Koch, O; Kölblinger, C; Mischinger, HJ; Schima, W; Schöllnast, H; Stättner, S; Kaczirek, K Austrian consensus guidelines on imaging requirements prior to hepatic surgery and during follow-up in patients with malignant hepatic lesions.
Wien Klin Wochenschr. 2018; 130(21-22):665-672 Doi: 10.1007/s00508-018-1387-z [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Posch, F; Leitner, L; Bergovec, M; Bezan, A; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Leithner, A; Szkandera, J Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Clin Orthop Relat Res. 2017; 475(5):1427-1435 Doi: 10.1007/s11999-017-5232-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Andreou, D; Werner, M; Pink, D; Traub, F; Schuler, MK; Gosheger, G; Jobke, B; Reichardt, P; Tunn, PU Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.
Int J Hyperthermia. 2016; 32(2): 159-64. Doi: 10.3109/02656736.2015.1109146
Web of Science PubMed FullText FullText_MUG

 

2015

Andreou, D; Werner, M; Pink, D; Traub, F; Schuler, M; Gosheger, G; Jobke, B; Reichardt, P; Tunn, PU Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma.
Br J Cancer. 2015; 112(3): 455-60. Doi: 10.1038/bjc.2014.635 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Gakis, G; Morgan, TM; Daneshmand, S; Keegan, KA; Todenhöfer, T; Mischinger, J; Schubert, T; Zaid, HB; Hrbacek, J; Ali-El-Dein, B; Clayman, RH; Galland, S; Olugbade, K; Rink, M; Fritsche, HM; Burger, M; Chang, SS; Babjuk, M; Thalmann, GN; Stenzl, A; Efstathiou, JA Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.
Ann Oncol. 2015; 26(8):1754-1759 Doi: 10.1093/annonc/mdv230 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Golcher, H; Brunner, TB; Witzigmann, H; Marti, L; Bechstein, WO; Bruns, C; Jungnickel, H; Schreiber, S; Grabenbauer, GG; Meyer, T; Merkel, S; Fietkau, R; Hohenberger, W Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trial.
Strahlenther Onkol. 2015; 191(1):7-16 Doi: 10.1007/s00066-014-0737-7 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hilbe, W; Pall, G; Kocher, F; Pircher, A; Zabernigg, A; Schmid, T; Schumacher, M; Jamnig, H; Fiegl, M; Gächter, A; Freund, M; Kendler, D; Manzl, C; Zelger, B; Popper, H; Wöll, E Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study).
PLoS One. 2015; 10(5):e0125364-e0125364 Doi: 10.1371/journal.pone.0125364 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Rouprêt, M; Babjuk, M; Compérat, E; Zigeuner, R; Sylvester, RJ; Burger, M; Cowan, NC; Böhle, A; Van Rhijn, BW; Kaasinen, E; Palou, J; Shariat, SF European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
Eur Urol. 2015; 68(5):868-879 Doi: 10.1016/j.eururo.2015.06.044
Web of Science PubMed FullText FullText_MUG

 

2014

Hoeppner, J; Zirlik, K; Brunner, T; Bronsert, P; Kulemann, B; Sick, O; Marjanovic, G; Hopt, UT; Makowiec, F Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.
J Surg Oncol. 2014; 109(3):287-93 Doi: 10.1002/jso.23498
Web of Science PubMed FullText FullText_MUG

 

Steger, GG; Greil, R; Lang, A; Rudas, M; Fitzal, F; Mlineritsch, B; Hartmann, BL; Bartsch, R; Melbinger, E; Hubalek, M; Stoeger, H; Dubsky, P; Ressler, S; Petzer, AL; Singer, CF; Muss, C; Jakesz, R; Gampenrieder, SP; Zielinski, CC; Fesl, C; Gnant, M Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
ANN ONCOL. 2014; 25(2): 366-371. Doi: 10.1093/annonc/mdt508 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ugurel, S; Mentzel, T; Utikal, J; Helmbold, P; Mohr, P; Pföhler, C; Schiller, M; Hauschild, A; Hein, R; Kämpgen, E; Kellner, I; Leverkus, M; Becker, JC; Ströbel, P; Schadendorf, D Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up.
Clin Cancer Res. 2014; 20(2):499-510 Doi: 10.1158/1078-0432.CCR-13-1411 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Gampenrieder, SP; Rinnerthaler, G; Greil, R Neoadjuvant chemotherapy and targeted therapy in breast cancer: past, present, and future.
J Oncol. 2013; 2013: 732047 Doi: 10.1155/2013/732047 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

2012

Roupret, M; Zigeuner, R; Palou, J; Boehle, A; Kaasinen, E; Sylvester, R; Babjuk, M; Oosterlinck, W; European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract.
Actas Urol Esp. 2012; 36(1): 2-14. Doi: 10.1016/j.acuro.2011.09.001 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2007

Steger, GG; Galid, A; Gnant, M; Mlineritsch, B; Lang, A; Tausch, C; Rudas, M; Greil, R; Wenzel, C; Singer, CF; Haid, A; Postlberger, S; Samonigg, H; Luschin-Ebengreuth, G; Kwasny, W; Klug, E; Kubista, E; Menzel, C; Jakesz, R Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.
J Clin Oncol. 2007; 25(15):2012-2018 Doi: 10.1200/JCO.2006.09.1777 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1999

Bauernhofer, T; Stöger, H; Kasparek, AK; Ploner, F; Kuss, I; Pieber, TR; Kotz, R; Samonigg, H Combined treatment of metastatic osteosarcoma of the spine.
Oncology. 1999; 57(4):265-268 Doi: 10.1159/000012058 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum